Not a good buy right now for an impatient buyer: price is sitting at/near resistance (~85.28) while fundamentals and Street targets point to limited near-term upside.
Short-term technicals are strong but look stretched (RSI elevated) and the pattern-based outlook expects a weak next week (~-3.97%), which is a poor setup if you don’t want to wait for a better entry.
Options positioning is mildly constructive (OI put/call < 1), but volume put/call is ~neutral and overall activity isn’t showing a strong “risk-on” push.
Moving averages: converging MAs suggest consolidation rather than a clean breakout trend.
Key levels: Pivot 81.67; immediate resistance R1 85.28 (price ~85.14 pre-mkt is right below it); next resistance R2 87.51; supports S1 78.05 and S2 75.82.
Near-term probability snapshot (pattern analogs): 70% chance of only ~+0.25% next day, but a weak next-week bias (-3.97%), then modest next-month upside (~+4%).
Options Data
Bullish
Open Interest Put-Call Ratio
Neutral
Option Volume Put-Call Ratio
Sentiment: Open interest put/call 0.8 implies slightly bullish positioning/less demand for downside hedges; volume put/call 0.99 is essentially neutral on the day.
Activity: Today’s volume (506) is 54% of 30-day average (not a high-conviction flow day), while open interest is elevated vs its 30-day average (112%), implying existing positioning matters more than fresh betting.
Volatility: IV Rank 4.63 and IV percentile 14.8 are low (options relatively “cheap”); IV (30d) ~32.4 vs HV ~25.0 suggests options still price more movement than realized, but not extreme.
Technical Summary
Sell
7
Buy
4
Positive Catalysts
Technical momentum is currently positive (MACD expanding), which can support short-term strength if price cleanly breaks above ~85.28 and holds.
Low IV rank/percentile can make directional option structures relatively cost-efficient if a catalyst emerges.
General market tone pre-mkt is slightly positive (S&P 500 +0.16%).
Neutral/Negative Catalysts
with an overbought RSI, which often leads to rejection/pullback rather than immediate continuation.
Financial Performance
Latest quarter: 2026/Q2 showed a clear downcycle.
Revenue: 769.5M, -19.40% YoY.
Net income: 102.8M, -53.09% YoY.
EPS: 2.13, -52.35% YoY.
Gross margin: 26.95, -27.73% YoY.
Takeaway: earnings power is contracting meaningfully versus last year, consistent with falling egg prices and weaker industry setup—this limits the case for chasing the stock at resistance.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: multiple price target cuts into early Jan 2026, with ratings staying Market Perform / Equal Weight (neutral stance).
Pros: recognition of improved longer-term earnings durability.
Cons: near-term fundamentals weakening; targets now cluster around ~85, roughly where the stock is trading—implying limited upside from here.
Wall Street analysts forecast CALM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CALM is 90 USD with a low forecast of 85 USD and a high forecast of 100 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast CALM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CALM is 90 USD with a low forecast of 85 USD and a high forecast of 100 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 84.280
Low
85
Averages
90
High
100
Current: 84.280
Low
85
Averages
90
High
100
BMO Capital
Market Perform
downgrade
$97 -> $85
AI Analysis
2026-01-08
Reason
BMO Capital
Price Target
$97 -> $85
AI Analysis
2026-01-08
downgrade
Market Perform
Reason
BMO Capital lowered the firm's price target on Cal-Maine Foods to $85 from $97 and keeps a Market Perform rating on the shares. The price target reduction reflects deteriorating fundamentals, the analyst tells investors in a research note.
Stephens
Pooran Sharma
Equal Weight
downgrade
$95 -> $85
2026-01-08
Reason
Stephens
Pooran Sharma
Price Target
$95 -> $85
2026-01-08
downgrade
Equal Weight
Reason
Stephens analyst Pooran Sharma lowered the firm's price target on Cal-Maine Foods to $85 from $95 and keeps an Equal Weight rating on the shares. Cal-Maine reported Q2 adjusted EPS that beat the firm's and consensus estimates, but earnings declined meaningfully year-over-year as egg prices continued to fall from multi-year highs seen earlier this past spring, the analyst tells investors. While the firm is "encouraged" by the improvement in longer-term earnings durability, it expects oversupply concerns and seasonal demand weakness to weigh on the near- to intermediate-term setup, the analyst tells investors.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CALM
